MCM3AP and lung carcinoma: YY1-mediated ZFPM2-AS1 promotes down-regulation of miR-3612 activity, while TNF receptor-associated factor 4 (TRAF4) interacts with miR-3612 in lung cancer.[14] YY1-induced MCM3AP-AS1 promotes cell proliferation, migration and angiogenesis in lung cancer cells by targeting miR-340-5p/Karyopherin α 4 axis.